HALOPERIDOL (is an active metabolite) | HALOPERIDOL | ATC N05AD01
NERVOUS SYSTEM ANTIPSYCHOTIC TREATMENT OF SCHIZOPHRENIA ANTIDYSKINETICS DOPAMINE ANTAGONISTS A BUTYROPHENONE NEUROLEPTIC AGENT | ORAL INJECTION | Cmax 15.3 NANOMOLAR Tmax 4 HOUR F 60 PERCENT VD 1105 LITER (65 KILOGRAM) PPB 92 PERCENT Cl 30.4 LITER / HOUR (65 KILOGRAM) HT 35 HOUR | D(1A) DOPAMINE RECEPTOR D(2) DOPAMINE RECEPTOR PDB 6DJZ (HUMAN SIGMA-1 RECEPTOR BOUND TO HALOPERIDOL) LIGAND CODE = GMJ (link to the list of PDB complexes) Download experimental 3D coordinates of GMJ with added hydrogens | D2-LIKE DOPAMINE RECEPTOR INVERSE AGONIST CHEMBL2331075 D2-LIKE DOPAMINE RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
HALOPERIDOL DECANOATE (has an active metabolite) | HALOPERIDOL DECANOATE | ATC N05AD01
NERVOUS SYSTEM ANTIPSYCHOTIC DOPAMINE ANTAGONIST DECANOATE ESTER OF THE BUTYROPHENONE BLOCKS THE EFFECTS OF DOPAMINE THE TREATMENT OF SCHIZOPHRENIC PATIENTS BUTYROPHENONE DERIVATIVES | INJECTION | SOLUBILITY ALMOST INSOLUBLE IN WATER 0.01 MILLIGRAM / MILLILITER | DOPAMINE D2 RECEPTOR | D2-LIKE DOPAMINE RECEPTOR INVERSE AGONIST CHEMBL2331075 D2-LIKE DOPAMINE RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |